Guangxi University of Chinese Medicine, Nanning, 530001, Guangxi, China.
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, 530022, Guangxi, China.
Exp Cell Res. 2022 Oct 15;419(2):113302. doi: 10.1016/j.yexcr.2022.113302. Epub 2022 Aug 17.
Ischemic stroke (IS) is the most common type of stroke, and its pathophysiological process is more complex. In recent years, the key regulatory roles of non-coding RNA (miRNA, circRNA) and mRNA in the development of IS have attracted more attention. In the process of cerebral ischemia/reperfusion injury, circRNA can regulate nerves, blood vessels and immune system through miRNA/mRNA axis, so as to affect the neurovascular unit of IS. The combination of these noncoding RNAs and mRNAs can be used as non-invasive biomarkers and therapeutic tools for IS diagnosis, prognosis and brain injury. Therefore, it is very important to study the potential molecular mechanism, activation pathway and treatment methods of circRNA/miRNA/mRNA network in IS. This review will focus on the latest progress of circRNA/miRNA/mRNA regulatory network, we have also included some circRNAs, which does not mediate through a miRNA, so we also include circRNA -mRNA network. And explore the application prospect of these RNAs as potential therapeutic targets in the prevention and treatment of IS.
缺血性脑卒中(IS)是最常见的脑卒中类型,其病理生理过程较为复杂。近年来,非编码 RNA(miRNA、circRNA)和 mRNA 在 IS 发生发展中的关键调控作用引起了更多关注。在脑缺血/再灌注损伤过程中,circRNA 可通过 miRNA/mRNA 轴调节神经、血管和免疫系统,从而影响 IS 的神经血管单元。这些非编码 RNA 和 mRNAs 的组合可作为 IS 诊断、预后和脑损伤的无创生物标志物和治疗工具。因此,研究 circRNA/miRNA/mRNA 网络在 IS 中的潜在分子机制、激活途径和治疗方法非常重要。本综述将重点关注 circRNA/miRNA/mRNA 调控网络的最新进展,我们还纳入了一些不通过 miRNA 介导的 circRNA,因此我们也纳入了 circRNA-mRNA 网络。并探讨这些 RNA 作为潜在治疗靶点在 IS 防治中的应用前景。